MARKET

BLFS

BLFS

BioLife
NASDAQ

Real-time Quotes | Nasdaq Last Sale

40.71
-2.02
-4.73%
Opening 12:56 01/22 EST
OPEN
41.68
PREV CLOSE
42.73
HIGH
42.76
LOW
40.50
VOLUME
174.13K
TURNOVER
--
52 WEEK HIGH
47.22
52 WEEK LOW
7.37
MARKET CAP
1.33B
P/E (TTM)
-150.4435
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Insider Trends: Biolife Solutions Insider Continues 90-Day Selling Trend
MT Newswires · 21h ago
Biopreservation Market Share, Size Global Top Leading Countries, Companies, Consumption, Drivers, Trends, Forces Analysis, Revenue, Challenges and Global Forecast to 2024
Jan 21, 2021 (The Expresswire) -- Global Biopreservation Market research report provides a Point-by-Point In-Depth analysis of global market size, regional...
The Express Wire · 1d ago
Transplantation Market 2021 Size, Swot Analysis, Business Opportunity, Applications, Trends and Forecast to 2025
Jan 20, 2021 (AmericaNewsHour) -- REPORT HIGHLIGHT The transplantation market was valued at USD 24.93 billion by 2017, growing with 8.8% CAGR during the...
AmericaNewsHour · 1d ago
Global Bio-Preservation Market 2021 Segmentation and Analysis by Recent Trends, consumption by Regional data, Development, Investigation, Growth by to 2026
Jan 20, 2021 (The Expresswire) -- Bio-Preservation Market provides detailed analysis of Market Overview, Drivers, Prospects, Potential Application. Also...
The Express Wire · 1d ago
Biolife Solutions (BLFS) sees Significant Insider Selling Continuing
MT Newswires · 1d ago
BioLife Solutions (BLFS) Shines Amidst the Pandemic
Wasatch Advisors, an employee-owned investment manager, published its ‘Wasatch Micro Cap Value Fund’ third-quarter 2020 Investor Letter – a copy of which can be downloaded here. A return of 11.62% was recorded by the fund for the Q3 of 2020, above its Russ...
Insider Monkey · 2d ago
Insider Trends: Selling By Insiders Lingers at Biolife Solutions
MT Newswires · 2d ago
Hybrid Composites Market Trends-2021: Price, Raw Materials, Supply-Demand, Growth | Toray Composite Materials America Inc, Koninklijke DSM N.V.
Jan 19, 2021 (WiredRelease via Comtex) -- A consciously conceived and designed business intelligence report titled Global Hybrid Composites market 2021 by...
marketresearch.biz · 3d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BLFS. Analyze the recent business situations of BioLife through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BLFS stock price target is 44.21 with a high estimate of 55.00 and a low estimate of 35.50.
EPS
Institutional Holdings
Institutions: 142
Institutional Holdings: 23.37M
% Owned: 71.37%
Shares Outstanding: 32.74M
TypeInstitutionsShares
Increased
41
5.05M
New
40
3.16M
Decreased
20
1.07M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.16%
Healthcare Equipment & Supplies
-0.07%
Key Executives
Chairman/Independent Director
Raymond Cohen
President/Chief Executive Officer/Director
Michael Rice
Chief Financial Officer/Chief Operating Officer/Secretary/IR Contact Officer
Roderick de Greef
Executive Vice President/Chief Scientific Officer
Aby Mathew
Chief Marketing Officer
Todd Berard
Vice President/Director of Sales
Marcus Schulz
Vice President/Director of Human Resources
Sarah Aebersold
Other
Karen Foster
Independent Director
Andrew Hinson
Independent Director
Joseph Schick
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BLFS
BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.
More

Webull offers kinds of BioLife Solutions Inc stock information, including NASDAQ:BLFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLFS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BLFS stock methods without spending real money on the virtual paper trading platform.